Practice parameters for the management of anal fissures (revised).
Orsay
Charles
C
Rakinic
Jan
J
Perry
W Brian
WB
Hyman
Neil
N
Buie
Donald
D
Cataldo
Peter
P
Newstead
Graham
G
Dunn
Gary
G
Rafferty
Janice
J
Ellis
C Neal
CN
Shellito
Paul
P
Gregorcyk
Sharon
S
Ternent
Charles
C
Kilkenny
John
J
Tjandra
Joe
J
Ko
Clifford
C
Whiteford
Mark
M
Nelson
Richard
R
D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003107:Colorectal Surgery / Q000009:adverse effects / Q000379:methods / Q000592:standards; D019317:Evidence-Based Medicine / Q000592:standards; D005401:Fissure in Ano / Q000209:etiology / Q000628:therapy*; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use; D005996:Nitroglycerin / Q000627:therapeutic use; D018579:Patient Selection; D012107:Research Design / Q000592:standards; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use; D014945:Wound Healing
D002121:Calcium Channel Blockers; D009465:Neuromuscular Agents; D014665:Vasodilator Agents; D019274:Botulinum Toxins, Type A; D005996:Nitroglycerin